SEPTInvestingStart Free

FBRX SCHEDULE 13G/A: SEC filing

OrbiMed Advisors LLC and affiliated entities

Filed with the SEC on · accession 0000947871-26-000799

FBRX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. OrbiMed Advisors LLC and affiliated entities filed Amendment No. 2 to their Schedule 13G regarding their passive ownership position in Forte Biosciences, Inc. common stock. The stock moved -0.0% by the first close after the filing.

Summary of the filing

OrbiMed Advisors LLC and affiliated entities filed Amendment No. 2 to their Schedule 13G regarding their passive ownership position in Forte Biosciences, Inc. common stock. The filing includes a joint filing agreement executed by the OrbiMed entities.

For details, click here →

Key details

Filer / beneficial ownerOrbiMed Advisors LLC
Co-filerOrbiMed Capital GP IX LLC
Co-filerOrbiMed Capital LLC
IssuerForte Biosciences, Inc.
Member, orbimed advisors llcCarl L. Gordon

How FBRX stock reacted

Close before

$76.86

Aug 13, 2026

First close after

-0.04%

$76.83

5 trading days

+0.04%

$76.89

Since filing

+0.17%

$76.99

✦ Ask GOAX AI about this filing — what it means for FBRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for FBRX?

Click here

Frequently asked questions

What did FBRX file with the SEC on Aug 14, 2026?

FBRX filed a SCHEDULE 13G/A (SEC filing). OrbiMed Advisors LLC and affiliated entities filed Amendment No. 2 to their Schedule 13G regarding their passive ownership position in Forte Biosciences, Inc. common stock. The filing includes a joint filing agreement executed by the OrbiMed entities.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did FBRX stock react to this filing?

FBRX closed at $76.86 before the filing and $76.83 on Aug 14, 2026 (-0.04%). Five trading days later: $76.89 (+0.04%).

Other FBRX SEC filings

Get alerts when FBRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
FBRX overviewFBRX analysisFBRX newsLatest SEC filings